Navigation Links
'Missing Link' Stem Cells may Shorten Path to Therapies

The discovery of a mouse embryonic stem cell startlingly similar to its human counterpart will likely speed progress toward the regeneration of healthy cells and organ tissue in people, two studies reported Wednesday.

The newly-found "epiblast" stem cells, taken from the inner-most layer of week-old rodent embryos, will provide a better model in testing potential therapies for human diseases and injuries, the researchers said.

"They are a missing link between mouse and human embryonic stem cells," Roger Pedersen, who headed a research team at Cambridge University, told AFP.

The other group was led by Ronald McKay at Oxford.

Both studies, published in Nature, were hailed by other scientists as a breakthrough that would shed light on the origin of human embryo stem cells and help fulfill the rich promise of cell-based medicine.

Adult bone-marrow stem cells are already used in the treatment of leukemia, and experiments suggest stems cells could also yield effective treatments for Parkinson's and Alzheimer's disease, spinal cord injury, heart disease, diabetes, osteoarthritis, and numerous other illnesses.

One of the great challenges of cell biology is figuring out how stem cells -- found in embryos and in certain adult tissues -- remain unspecialized or "pluripotent," maintaining the capacity to become virtually any type of cell found in blood, nerves and individual organs.

Another difficulty is identifying the molecular signals that trigger this transformation.

Scientists have successfully grown mice embryo stem-cell lines in the laboratory for decades, and human ones since the late 1990s.

But until today the two kinds of cells looked and behaved very differently, limiting the parallels that could be drawn between the two species and raising questions about what accounted for the divergence.

"It was perplexing," Pedersen told AFP . "Was is it the evolutionary divergence of mice and men, or was there a developmental explanation, reflecting different stages of growth?"

This question spurred Pedersen and his team to challenge conventional wisdom and see whether the bio-chemical conditions used to maintain human embryo stem cells might work for mice too.

Previous attempts had failed. But when the researchers applied the human-specific molecular cocktail to a later stage of the mouse embryo rather than the three-day old blastocyst stage from which stem cells had always been drawn, suddenly it worked.

"Comparative analyses suggest that the new cells may have more in common with human embryo stem cells" than the ones taken earlier in the life cycle from mice, commented Ian Chambers, the head of embryonic stem cell biology at the University of Edinburgh, in an e-mail.

"These are exciting findings that hint at ways in which it may be possible to alter the culture conditions for human embryo stem cells in order to make their maintenance more straightforward and malleable," he said after reviewing the studies.

Kevin Eggan, a researcher at the Harvard Stem Cell Institute, also welcomed the studies, saying they could "shed light on the origin and nature of human embryonic stem cells."

The discovery of the epiblast stem cells in mice should make it easier to isolate stem cells in other species, livestock, as well as mice genetically modified to express a disease so that it can be studied, the authors of the studies said.

The growth factor -- called activin/Nodal -- that is now known to work for humans and mice may also unlock access to stem cells in these other species, said Pedersen.

One persistent problem in trying to use stem cells to produce specialised cells for treatment -- to make insulin in the pancreas or beating-heart cells, for example -- is an extremely low efficiency.

On average, less than one percent of cells develop along the desired pathway in most experiments.

"We have not yet gained control over specialisation in the petri dish," said Pedersen. "That, really, is the Holy Grail -- a profound understanding of what makes things happen in the early development of embryonic stem cells."


'"/>




Related medicine news :

1. Gene linked to Missing Eye condition in newborns
2. Blood Cells Capable of Regenerating Liver
3. White Cells Count Can Predict Heart Attack Death Risk
4. Gene Therapy Destroys Pancreatic Cancer Cells
5. Stem Cells Have Few Mutations
6. Heart may pull Cells from Body to Self-repair
7. Cells critical for asthma development found
8. Vitamin D Wipes out Cancer Cells
9. Bone Marrow Cells Help Heart Attack Patients
10. Islet Cells May Lead to Diabetes CureChildren
11. Stem Cells Found To Offer Promise For Hair Growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
Breaking Medicine Technology: